Dan Burrows

Dan Burrows

Dan Burrows is a veteran of CBS MoneyWatch, DailyFinance, SmartMoney and Dow Jones MarketWatch, and has written for The Wall Street Journal, Consumer Reports and other publications. He favors value investing and writes about asset prices and macroeconomic trends for the long-term investor. He holds no individual securities.

Recent Articles

Big Banks Pile Up Victories — at What Cost?

They're scoring on all fronts -- litigation, regulations and profitability. The glaring exception is in the failure to ensure the system's future safety.

Morgan Stanley Can’t Cut Its Way to Growth

The days of sizzling revenue growth long gone, and the latest layoffs are a grim reminder of how bad things are now.

No Recession Here! Manufacturing Signals Growth Ahead

The most recent reading of manufacturing production wasn't a screaming, blow-out number -- but it does help quell fears about a slip toward recession.

Why Pfizer Has to Buy Agila Injectable Drugs

A quick infusion of generic drugs -- via India's Agila Specialties -- could lessen the blow from Pfizer's expiring patents.

Hedge Funds Battling Over Herbalife? Run!

Don't get caught between these titans as they do battle. On one side is Bill 'Pyramid Scheme' Ackman. On the other, Dan 'Buy It' Loeb. Oy.

Gundlach: Go Long on China, Then Short the S&P 500 and Apple

Jeff Gundlach, who has an uncanny knack for contrarian and market-crushing calls, sees poor times ahead for the S&P 500 and Apple.

Small-Caps at All-Time Highs, But Can It Last?

The macro backdrop looks good, but if earnings are as bad as expected, small caps could turn south in a hurry.

Alcoa: From Bellwether to Red Herring

Alcoa's fourth-quarter earnings expectations look rosy -- which is better than you can say for the broader market

Why Rock Star CEOs Are WAY Overpaid

Coinstar got hit on news of CEO Paul Davis' decision to depart, but research suggests its decision to hire from within has a better chance than making a flashy outside hire.

Wendy’s Hikes Prices — Here Come Falling Sales

Dollar-menu items are killing its already scant operating profit margins, but higher prices will likely punish the top line, making things even worse.